| Value | ₹326.1 Cr |
|---|
BSE filing, NSE: IKIO. Summary written from the filing by ALFA Finder's alert engine.
IKIO Technologies Ltd: key numbers
- Share price
- ₹161.01
- Market cap
- ₹1,244 Cr
- Revenue (annual)
- ₹595.3 Cr
- Net profit (annual)
- ₹37.83 Cr
- P/E (TTM)
- 26.8×Sector 40.5×
- Promoter holding
- 72.55%+0.00% QoQ
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IKIO Technologies Ltd
All →IKIO Technologies Board Meeting Date
IKIO Technologies has scheduled a board meeting on 5 November 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. This is an advance notice; the results are not yet approved.
IKIO Technologies Other Announcement
IKIO Technologies filed its Reg 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. It is a routine compliance certificate with no transaction or business impact.
IKIO Technologies Business Update
IKIO Technologies' subsidiary, Royalux FZCO, entered a one-year vendor exclusivity undertaking with Danube Home LLC, targeting AED 2 million in potential business opportunities.
- Execution
- 1 year
IKIO Technologies Management Change
IKIO Technologies Limited announced the resignation of Assistant Vice President Nripendra Kumar Gupta and the appointment of Naveen Bhatia as Finance Head.
IKIO Technologies Price Movement Clarification
IKIO Technologies clarified that the recent increase in its stock trading volume is market-driven. The company confirmed it has no pending material information for disclosure.
IKIO Technologies Earnings Call Transcript: Key Takeaways
IKIO reported strong Q1 FY27 results with 41% revenue growth driven by non-lighting diversification. Management focus remains on reducing ODM home lighting reliance while scaling new segments and manufacturing capacity.
- Call
- Guides 20% growth
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr